France vs Germany: Reported rate of new cervical cancer cases
France
6.89 per 100,000 women
in 2017
Germany
7.49 per 100,000 women
in 2017
France rank
27th
Germany rank
24th
Reported rate of new cervical cancer cases over time
- France
- Germany
How they compare
Germany currently reports 7.49 per 100,000 women against 6.89 per 100,000 women in France, a difference of 0.6 per 100,000 women.
That makes Germany's figure about 1.1 times France's.
Across all 15 years both countries report, Germany has been ahead every year.
France ranks 27th and Germany ranks 24th of 46 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.61 per 100,000 women | 8.54 per 100,000 women | 1.93 per 100,000 women | Germany |
| 2010s | 6.28 per 100,000 women | 8.03 per 100,000 women | 1.75 per 100,000 women | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, France or Germany?
- Germany, at 7.49 per 100,000 women against 6.89 per 100,000 women in France as of 2017.
- What is the difference in reported rate of new cervical cancer cases between France and Germany?
- 0.6 per 100,000 women, with Germany ahead.
- How many years of comparable data are there for France and Germany?
- 15 years are reported by both, from 2003 to 2017.
- How do France and Germany rank globally for reported rate of new cervical cancer cases?
- France ranks 27th and Germany ranks 24th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.